Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives

References

• EmamiBLymanJBrownATolerance of normal tissue to therapeutic irradiationInt J Radiat Oncol Biol Phys19912111091222032882
   PubMed Web of Science ®Google Scholar
• Hauer-JensenMWangJDenhamJWBowel injury: current and evolving management strategiesSemin Radiat Oncol200313335737112903023
   PubMed Web of Science ®Google Scholar
• BuchiKRadiation proctitis: therapy and prognosisJAMA1991265911801996006
   PubMed Web of Science ®Google Scholar
• HasletonPSCarrNSchofieldPFVascular changes in radiation bowel diseaseHistopathology1985955175344007790
   PubMed Web of Science ®Google Scholar
• FajardoLFThe pathology of ionizing radiation as defined by morphologic patternsActa Oncol2005441132215848902
   PubMed Web of Science ®Google Scholar
• ZelefskyMJFuksZHappersettLClinical experience with intensity modulated radiation therapy (IMRT) in prostate cancerRadiother Oncol200055324124910869739
   PubMed Web of Science ®Google Scholar
• ZietmanALDeSilvioMLSlaterJDComparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trialJAMA2005294101233123916160131
   PubMed Web of Science ®Google Scholar
• MerrickGSWallnerKEButlerWMBlaskoJCPermanent prostate brachytherapy: is supplemental external-beam radiation therapy necessary?Oncology (Williston Park)2006205514522 discussion 522–52516739748
   PubMed Web of Science ®Google Scholar
• MorrisWJTyldesleySRoddaSAndrogen suppression combined with elective nodal and dose escalated radiation therapy (the ASCENDE-RT Trial): an analysis of survival endpoints for a randomized trial comparing a low-dose-rate brachytherapy boost to a dose-escalated external beam boost for high- and intermediate-risk prostate cancerInt J Radiat Oncol Biol Phys201798227528528262473
   PubMed Web of Science ®Google Scholar
• GiordanoSHLeeAKuoYFFreemanJGoodwinJSLate gastrointestinal toxicity after radiation for prostate cancerCancer2006107242343216779795
   PubMed Web of Science ®Google Scholar
• Al-MamganiAvan PuttenWLHeemsbergenWDUpdate of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancerInt J Radiat Oncol Biol Phys200872498098818495377
   PubMed Web of Science ®Google Scholar
• DearnaleyDPSydesMRGrahamJDRT01 collaboratorsEscalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trialLancet Oncol20078647548717482880
   PubMed Web of Science ®Google Scholar
• KubanDATuckerSLDongLLong-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancerInt J Radiat Oncol Biol Phys2008701677417765406
   PubMed Web of Science ®Google Scholar
• ZelefskyMJLevinEJHuntMIncidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancerInt J Radiat Oncol Biol Phys20087041124112918313526
   PubMed Web of Science ®Google Scholar
• AlicikusZAYamadaYZhangZTen-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancerCancer201111771429143721425143
   PubMed Web of Science ®Google Scholar
• PeetersSTHeemsbergenWDvan PuttenWLAcute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 GyInt J Radiat Oncol Biol Phys20056141019103415752881
   PubMed Web of Science ®Google Scholar
• BoyerALAntonukLFensterAA review of electronic portal imaging devices (EPIDs)Med Phys19921911161620036
   PubMed Web of Science ®Google Scholar
• KesslerMLMcShanDLFraassBAA computer-controlled conformal radiotherapy system. III: graphical simulation and monitoring of treatment deliveryInt J Radiat Oncol Biol Phys1995335117311807493842
   PubMed Web of Science ®Google Scholar
• JaffrayDASiewerdsenJHWongJWMartinezAAFlat-panel cone-beam computed tomography for image-guided radiation therapyInt J Radiat Oncol Biol Phys20025351337134912128137
   PubMed Web of Science ®Google Scholar
• LuWOliveraGHChenQDeformable registration of the planning image (kVCT) and the daily images (MVCT) for adaptive radiation therapyPhys Med Biol200651174357437416912386
   PubMed Web of Science ®Google Scholar
• ShiratoHHaradaTHarabayashiTFeasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapyInt J Radiat Oncol Biol Phys200356124024712694845
   PubMed Web of Science ®Google Scholar
• BalterJMWrightJNNewellLJAccuracy of a wireless localization system for radiotherapyInt J Radiat Oncol Biol Phys200561393393715708277
   PubMed Web of Science ®Google Scholar
• RajendranRRPlastarasJPMickRMcMichael KohlerDKassaeeAVapiwalaNDaily isocenter correction with electromagnetic-based localization improves target coverage and rectal sparing during prostate radiotherapyInt J Radiat Oncol Biol Phys20107641092109919625136
   PubMed Web of Science ®Google Scholar
• ChungHTXiaPChanLWPark-SomersERoachM3rdDoes image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRTInt J Radiat Oncol Biol Phys2009731536018501530
   PubMed Web of Science ®Google Scholar
• FiorinoCValdagniRRancatiTSanguinetiGDose-volume effects for normal tissues in external radiotherapy: pelvisRadiother Oncol200993215316719765845
   PubMed Web of Science ®Google Scholar
• JacksonASkwarchukMWZelefskyMJLate rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histogramsInt J Radiat Oncol Biol Phys200149368569811172950
   PubMed Web of Science ®Google Scholar
• FiorinoCCozzariniCVavassoriVRelationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutionsRadiother Oncol200264111212208568
   PubMed Web of Science ®Google Scholar
• FiorinoCSanguinetiGCozzariniCRectal dose-volume constraints in high-dose radiotherapy of localized prostate cancerInt J Radiat Oncol Biol Phys200357495396214575825
   PubMed Web of Science ®Google Scholar
• RancatiTFiorinoCGagliardiGFitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101)Radiother Oncol2004731213215465142
   PubMed Web of Science ®Google Scholar
• VargasCMartinezAKestinLLDose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapyInt J Radiat Oncol Biol Phys20056251297130816029785
   PubMed Web of Science ®Google Scholar
• SöhnMYanDLiangJMeldolesiEVargasCAlberMIncidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability modelsInt J Radiat Oncol Biol Phys20076741066107317258870
   PubMed Web of Science ®Google Scholar
• FiorinoCFellinGRancatiTClinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective studyInt J Radiat Oncol Biol Phys20087041130113717881142
   PubMed Web of Science ®Google Scholar
• StoreyMRPollackAZagarsGSmithLAntolakJRosenIComplications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trialInt J Radiat Oncol Biol Phys200048363564211020558
   PubMed Web of Science ®Google Scholar
• HuangEHPollackALevyLLate rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancerInt J Radiat Oncol Biol Phys20025451314132112459352
   PubMed Web of Science ®Google Scholar
• van der LaanHPvan den BerghASchilstraCVlasmanRMeertensHLangendijkJAGrading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancerInt J Radiat Oncol Biol Phys20087041138114517931794
   PubMed Web of Science ®Google Scholar
• PeetersSTHoogemanMSHeemsbergenWDHartAAKoperPCLebesqueJVRectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modelingInt J Radiat Oncol Biol Phys2006661111916757129
   PubMed Web of Science ®Google Scholar
• MichalskiJMWinterKPurdyJAToxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IVInt J Radiat Oncol Biol Phys200458373574214967428
   PubMed Web of Science ®Google Scholar
• PeetersSTHoogemanMSHeemsbergenWDVolume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancerInt J Radiat Oncol Biol Phys20056341142115215939547
   PubMed Web of Science ®Google Scholar
• SchaakeWvan der SchaafAvan DijkLVBongaertsAHvan den BerghACLangendijkJANormal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patientsRadiother Oncol2016119338138727157889
   PubMed Web of Science ®Google Scholar
• MirjoletCWalkerPMGauthierMAbsolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancerRadiat Oncol201611114527814726
   PubMed Web of Science ®Google Scholar
• DréanGAcostaOOspinaJDIdentification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRTRadiother Oncol2016119338839727173457
   PubMed Web of Science ®Google Scholar
• BrennerDJMartinezAAEdmundsonGKMitchellCThamesHDArmourEPDirect evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissueInt J Radiat Oncol Biol Phys200252161311777617
   PubMed Web of Science ®Google Scholar
• MiralbellRRobertsSAZubizarretaEHendryJHDose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9–2.2) GyInt J Radiat Oncol Biol Phys2012821e17e2421324610
   PubMedGoogle Scholar
• ThamesHDBentzenSMTuressonIOvergaardMVan den BogaertWTime-dose factors in radiotherapy: a review of the human dataRadiother Oncol19901932192352281152
   PubMed Web of Science ®Google Scholar
• DearnaleyDSyndikusIMossopHCHHiP InvestigatorsConventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialLancet Oncol20161781047106027339115
   PubMed Web of Science ®Google Scholar
• LeeWRDignamJJAminMBRandomized phase III oninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancerJ Clin Oncol201634202325233227044935
   PubMed Web of Science ®Google Scholar
• CattonCNLukkaHGuCSRandomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancerJ Clin Oncol201735171884189028296582
   PubMed Web of Science ®Google Scholar
• IncrocciLWortelRCAlemayehuWGHypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trialLancet Oncol20161781061106927339116
   PubMed Web of Science ®Google Scholar
• BenjaminLCTreeACDearnaleyDPThe role of hypofractionated radiotherapy in prostate cancerCurr Oncol Rep20171943028343352
   PubMed Web of Science ®Google Scholar
• D’AmicoAVManolaJLoffredoMA practical method to achieve prostate gland immobilization and target verification for daily treatmentInt J Radiat Oncol Biol Phys20015151431143611728704
   PubMed Web of Science ®Google Scholar
• McGaryJETehBSButlerEBGrantW3rdProstate immobilization using a rectal balloonJ Appl Clin Med Phys20023161111817999
   PubMedGoogle Scholar
• TehBSWooSYMaiWYClinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilizationMed Dosim200227210511312074461
   PubMedGoogle Scholar
• van LinENvan der VightLPWitjesJAHuismanHJLeerJWVisserAGThe effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative studyInt J Radiat Oncol Biol Phys200561127828815629621
   PubMed Web of Science ®Google Scholar
• El-BassiouniMDavisJBEl-AttarIStuderGMLütolfUMCiernikIFTarget motion variability and on-line positioning accuracy during external-beam radiation therapy of prostate cancer with an endorectal balloon deviceStrahlenther Onkol2006182953153616944375
   PubMed Web of Science ®Google Scholar
• WachterSGerstnerNDornerDThe influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancerInt J Radiat Oncol Biol Phys20025219110011777626
   PubMed Web of Science ®Google Scholar
• HilleASchmidbergerHTöwsNWeissEVorwerkHHessCFThe impact of varying volumes in rectal balloons on rectal dose sparing in conformal radiation therapy of prostate cancer. A prospective three-dimensional analysisStrahlenther Onkol20051811170971616254706
   PubMed Web of Science ®Google Scholar
• ElsayedHBöllingTMoustakisCOrgan movements and dose exposures in teletherapy of prostate cancer using a rectal balloonStrahlenther Onkol20071831161762417960337
   PubMed Web of Science ®Google Scholar
• PatelRROrtonNTomeWAChappellRRitterMARectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancerRadiother Oncol200367328529412865176
   PubMed Web of Science ®Google Scholar
• van LinENHoffmannALvan KollenburgPLeerJWVisserAGRectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapyInt J Radiat Oncol Biol Phys200563256557616168848
   PubMed Web of Science ®Google Scholar
• van LinENKristinssonJPhilippensMEReduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopyInt J Radiat Oncol Biol Phys200767379981117161552
   PubMed Web of Science ®Google Scholar
• SchutzerMEOrioPFBiagioliMCAsherDALomasHMoghanakiDA review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacersProstate Cancer Prostatic Dis20151829610325687401
   PubMed Web of Science ®Google Scholar
• PradaPJGonzalezHMenéndezCTransperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patientsBrachytherapy20098221021719213607
   PubMed Web of Science ®Google Scholar
• NoyesWRHosfordCCSchultzSEHuman collagen injections to reduce rectal dose during radiotherapyInt J Radiat Oncol Biol Phys20128251918192221514738
   PubMed Web of Science ®Google Scholar
• MelchertCGezEBohlenGInterstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter studyRadiother Oncol2013106221021423484879
   PubMed Web of Science ®Google Scholar
• SusilRCMcNuttTRDeWeeseTLSongDEffects of prostate-rectum separation on rectal dose from external beam radiotherapyInt J Radiat Oncol Biol Phys20107641251125819939577
   PubMed Web of Science ®Google Scholar
• StromTJWilderRBFernandezDCA dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapyRadiother Oncol2014111112613124746567
   PubMed Web of Science ®Google Scholar
• BeydounNBucciJAChinYSMaloufDEnariEPainterSDFirst report of transperineal polyethylene glycol hydrogel spacer use to curtail rectal radiation dose after permanent iodine-125 prostate brachytherapyBrachytherapy201312436837423453682
   PubMed Web of Science ®Google Scholar
• MahalBAZiehrDRHyattASUse of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: initial experience and short-term resultsBrachytherapy201413544244924880584
   PubMed Web of Science ®Google Scholar
• AlongiFCozziLArcangeliSLinac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II studyRadiat Oncol2013817123835141
   PubMed Web of Science ®Google Scholar
• UhlMvan TriestBEbleMJWeberDCHerfarthKDe WeeseTLLow rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trialRadiother Oncol2013106221521923333011
   PubMed Web of Science ®Google Scholar
• EckertFAlloussiSPaulsenFProspective evaluation of a hydro-gel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancerBMC Cancer2013132723336502
   PubMed Web of Science ®Google Scholar
• PinkawaMPirothMDHolyRQuality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysisStrahlenther Onkol20121881091792522933033
   PubMed Web of Science ®Google Scholar
• MadsenBLHsiRAPhamHTFowlerJFEsaguiLCormanJStereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial resultsInt J Radiat Oncol Biol Phys20076741099110517336216
   PubMed Web of Science ®Google Scholar
• McBrideSMWongDSDombrowskiJJHypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trialCancer2012118153681369022170628
   PubMed Web of Science ®Google Scholar
• KatzAKangJStereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year studyRadiat Oncol20149124382205
   PubMed Web of Science ®Google Scholar
• LoblawACheungPD’AlimonteLProstate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomesRadiother Oncol2013107215315823647750
   PubMed Web of Science ®Google Scholar
• KangJKChoCKChoiCWImage-guided stereotactic body radiation therapy for localized prostate cancerTumori2011971434821528663
   PubMed Web of Science ®Google Scholar
• FreemanDEKingCRStereotactic body radiotherapy for low-risk prostate cancer: five-year outcomesRadiat Oncol20116321219625
   PubMed Web of Science ®Google Scholar
• KimDWChoLCStrakaCPredictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancerInt J Radiat Oncol Biol Phys201489350951724929162
   PubMed Web of Science ®Google Scholar
• HamstraDAMariadosNSylvesterJContinued benefit to rectal separation for prostate radiation therapy: final results of a phase III trialInt J Radiat Oncol Biol Phys201797597698528209443
   PubMed Web of Science ®Google Scholar
• BoermaMBurtonGRWangJFinkLMMcGeheeREJrHauer-JensenMComparative expression profiling in primary and immortalized endothelial cells: changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibitionBlood Coagul Fibrinolysis200617317318016575254
   PubMed Web of Science ®Google Scholar
• GauglerMHVereycken-HollerVSquibanCVandammeMVozenin-BrotonsMCBenderitterMPravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responsesRadiat Res2005163547948715850408
   PubMed Web of Science ®Google Scholar
• NübelTDamrotJRoosWPKainaBFritzGLovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaksClin Cancer Res2006123 Pt 193393916467108
   PubMed Web of Science ®Google Scholar
• RikitakeYKawashimaSTakeshitaSAnti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbitsAtherosclerosis20011541879611137086
   PubMed Web of Science ®Google Scholar
• MorikawaSTakabeWMatakiCThe effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cellsJ Atheroscler Thromb20029417818312226549
   PubMedGoogle Scholar
• WaehreTDamåsJKGullestadLHydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery diseaseJ Am Coll Cardiol20034191460146712742282
   PubMed Web of Science ®Google Scholar
• UndasABrozekJMusialJAnti-inflammatory and antithrombotic effects of statins in the management of coronary artery diseaseClin Lab2002485–628729612071579
   PubMedGoogle Scholar
• ShiJWangJZhengHStatins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulationBlood Coagul Fibrinolysis200314657558512960612
   PubMed Web of Science ®Google Scholar
• Pérez-GuerreroCAlvarez de SotomayorMJimenezLHerreraMDMarhuendaEEffects of simvastatin on endothelial function after chronic inhibition of nitric oxide synthase by L-NAMEJ Cardiovasc Pharmacol200342220421012883323
   PubMed Web of Science ®Google Scholar
• WedlakeLJSiliaFBentonBEvaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignanciesEur J Cancer201248142117212422386574
   PubMed Web of Science ®Google Scholar
• PalumboIMatroneFMontesiGStatins protect against acute RT-related rectal toxicity in patients with prostate cancer: an observational prospective studyAnticancer Res20173731453145728314317
   PubMed Web of Science ®Google Scholar
• AnscherMSChangMGMoghanakiDA phase II study to prevent radiation-induced rectal injury with lovastatinAm J Clin Oncol Epub2016719
   Web of Science ®Google Scholar
• SarosdyMFUrinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapyCancer2004101475476015305406
   PubMed Web of Science ®Google Scholar
• AkimotoTMuramatsuHTakahashiMRectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleedingInt J Radiat Oncol Biol Phys20046041033103915519772
   PubMed Web of Science ®Google Scholar
• LeeCMLeeRJHandrahanDLSauseWTComparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factorsUrology200565111411915667875
   PubMed Web of Science ®Google Scholar
• SherertzTWallnerKMerrickGFactors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancerBrachytherapy20043313013515533804
   PubMedGoogle Scholar
• TuckerSLDongLCheungRComparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapyInt J Radiat Oncol Biol Phys20046051589160115590191
   PubMed Web of Science ®Google Scholar
• WatermanFMDickerAPProbability of late rectal morbidity in 125I prostate brachytherapyInt J Radiat Oncol Biol Phys200355234235312527047
   PubMed Web of Science ®Google Scholar
• YoshiokaYNoseTYoshidaKHigh-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicityInt J Radiat Oncol Biol Phys200356121322012694841
   PubMed Web of Science ®Google Scholar
• AlbertMTempanyCMSchultzDLate genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapyCancer200398594995412942561
   PubMed Web of Science ®Google Scholar
• RyuJKWinterKMichalskiJMInterim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy)Int J Radiat Oncol Biol Phys20025441036104612419429
   PubMed Web of Science ®Google Scholar
• SkwarchukMWJacksonAZelefskyMJLate rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-responseInt J Radiat Oncol Biol Phys200047110311310758311
   PubMed Web of Science ®Google Scholar
• HoffmanKESkinnerHPughTJPatient-reported urinary, bowel, and sexual function after hypofractionated intensity-modulated radiation therapy for prostate cancer: results from a randomized trialAm J Clin Oncol Epub2016915
   Web of Science ®Google Scholar
• PollackAWalkerGHorwitzEMRandomized trial of hypo-fractionated external-beam radiotherapy for prostate cancerJ Clin Oncol201331313860386824101042
   PubMed Web of Science ®Google Scholar
• KatzAJKangJQuality of life and toxicity after SBRT for organ-confined prostate cancer, a 7-year studyFront Oncol2014430125389521
   PubMedGoogle Scholar
• ChenLNSuySUhmSStereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experienceRadiat Oncol201385823497695
   PubMed Web of Science ®Google Scholar
• KingCRBrooksJDGillHPrestiJCJrLong-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancerInt J Radiat Oncol Biol Phys201282287788221300474
   PubMed Web of Science ®Google Scholar
• World Endoscopy Organization [homepage on the Internet]Radiation proctitis2012 [cited December 25, 2012]. Available from: http://www.endoatlas.org/index.php?page=results_jquery&mstcat=3Accessed July 14, 2017
   Google Scholar
• LangSRiestererOProgress in Physics: Modern Techniques in Radiation OncologySPG Mitteilungen201341361922
   Google Scholar
• Augmenix, Inc. [homepage on the internet]Bedford, MA, USASpaceOAR^® system – spacing organs at risk Available from: http://review.augmenix.com/products/spaceoar/Accessed April 5, 2017
   Google Scholar